Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs-Reference-Cited by-同舟云学术

Risk Assessment of Drug‐Induced Long QT Syndrome for Some COVID‐19 Repurposed Drugs

Author:

Michaud Veronique¹²,Dow Pamela¹,Al Rihani Sweilem B.¹,Deodhar Malavika¹,Arwood Meghan¹,Cicali Brian³,Turgeon Jacques¹²

Affiliation:

1. Tabula Rasa HealthCare Precision Pharmacotherapy Research & Development Institute Orlando Florida USA

2. Faculty of Pharmacy Université de Montréal Montreal Quebec Canada

3. College of Pharmacy Lake Nona Campus University of Florida Orlando Florida USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

Reference50 articles.

1. US National Library of Medicine.ClinicalTrials.gov.COVID‐19.. Accessed August 13 2020.

2. Al Rihani S.B.et al.Potential COVID‐19 treatment options (Off‐label).. Accessed August 13 2020.

3. Simpson T. Kovacs R.J.&Stecker E.C.Ventricular arrhythmia risk due to hydroxychloroquine‐azithromycin treatment for COVID‐19. (2020).

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献